Estimated Annual Pharmaceutical Revenue Loss Due to Medication Non-Adherence

| Point of View

Pharmaceutical Market Failing to Capture Significant Revenue Due to Medication Non-Adherence

Capgemini Consulting and HealthPrize report reveals key revenue loss across 100 therapeutic areas including chronic conditions such as diabetes, hypertension and high cholesterol, and critical conditions such as HIV, cancer and transplant.